CSA Medical
PrivateLast Round
Seed Round
Jul 23, 2026
Total Funding Raised
$206.42M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
CSA Medical is a medical device company that develops and commercializes the RejuvenAir® System, a liquid nitrogen spray cryotherapy technology for the treatment of chronic bronchitis.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CSA Medical Comparables
Compare CSA Medical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Galvanize Therapeutics | 88% | |
| Free Flow Medical, Inc. | 84% | |
| Nuvaira | 82% |
CSA Medical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Jul 23, 2026 | ||||
| Series D | Sep 9, 2024 | ||||
| Debt | Feb 8, 2019 | ||||
| Growth Equity | Jan 25, 2019 | ||||
| Growth Equity | Oct 8, 2018 | ||||
Debt | Oct 8, 2018 |
Key People
Founding team and executive leadership
CSA Medical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ascension Ventures | Growth Equity, Series D, Series C |
| SV Health Investors | Debt, Series C, Growth Equity, Series B, Series D |
| First Analysis | Series C, Series D, Series B |
| Ascension Ventures | Debt, Series D, Series C |
| TVM Capital | Series D |
| Guide Medical Ventures | Series C |
| Rose Park Advisors | Series C, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 14, 2026
Monthly visitors grew 368% MoM, reaching 2.2K.
- Aug 20, 2026
Monthly visitors increased 233% MoM.
CSA Medical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about CSA Medical's valuation, stock price, and market status.
Is CSA Medical a public or private company?
CSA Medical is a private company.
What is the current stock price of CSA Medical?
CSA Medical is a private company, so its shares have no public market price. Caplight tracks CSA Medical's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is CSA Medical worth (valuation)?
Valuation information for CSA Medical is not publicly available.
Can I buy CSA Medical stock?
CSA Medical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was CSA Medical's last funding round?
CSA Medical's most recent funding round was Seed Round on July 23, 2026.
Who are the main investors in CSA Medical?
Key investors in CSA Medical include Ascension Ventures, First Analysis, Ascension Ventures, TVM Capital, New Markets Venture Partners.
Will CSA Medical IPO soon?
No public IPO plans have been announced for CSA Medical.
How can I track CSA Medical secondary market activity?
Caplight tracks bids, offers, and trades in CSA Medical's shares on secondary markets.